Human Vaccines & Immunotherapeutics,
Journal Year:
2022,
Volume and Issue:
18(6)
Published: Aug. 5, 2022
This
article
refers
to:Self-Reported
adverse
events
among
Chinese
healthcare
workers
immunized
with
COVID-19
vaccines
composed
of
inactivated
SARS-CoV-2Side
effects
SARS-CoV-2
should
be
assessed
by
unbiased
professionals
on-site
Journal of Infection and Public Health,
Journal Year:
2023,
Volume and Issue:
16(5), P. 697 - 704
Published: March 2, 2023
COVID
-
19
vaccine
can
lead
to
various
local
and
systemic
side
effects,
including
menstrual
irregularities
in
women.
There
is
no
robust
quantitative
evidence
of
the
association
between
irregularities.
A
meta-analysis
was
performed
estimate
pooled
prevalence
a
range
disorders
that
may
occur
women
following
vaccination.After
searching
for
epidemiological
studies,
we
systematically
on
PubMed/Medline,
EMBASE,
Science
Direct.
Sixteen
studies
were
finally
included
study.
We
estimated
corresponding
95
%
confidence
intervals
(CIs)
group
disorders,
menorrhagia,
polymenorrhea,
abnormal
cycle
length,
oligomenorrhea.
Heterogeneity
assessed
using
I2
statistic
Q
test.Overall,
menorrhagia
24.24
(pooled
%;
CI:
12.8-35.6
%).
The
polymenorrhea
16.2
prevalence:
10.7-21.6
length
relatively
lower
than
other
6.6
5.0-8.2
oligomenorrhea
22.7
(95
13.5-32.0
%).The
findings
indicate
oligomenorrhea,
most
common
after
vaccination.
also
suggest
high
proportion
suffer
from
Further
longitudinal
are
needed
confirm
causal
relationship
COVID-19
vaccination
Frontiers in Drug Safety and Regulation,
Journal Year:
2024,
Volume and Issue:
4
Published: Jan. 31, 2024
Introduction:
Menstrual
disorders
are
commonly
reported
after
COVID-19
vaccination
and
heavy
menstrual
bleeding
was
added
to
the
product
information
of
vaccines
Moderna
Pfizer.
The
aim
this
review,
using
a
systematic
search,
is
provide
an
overview
available
literature
on
risk
vaccination.
Methods:
review
conducted
according
Preferred
Reporting
Items
for
Systematic
reviews
Meta-Analysis
(PRISMA)
guidelines.
A
PubMed
search
performed
15
August
2023,
including
solely
quantitative
studies
in
English
Dutch.
Results:
total
61
were
included,
which
40
cross-sectional
studies,
18
cohort
three
self-controlled
case
series.
Outcomes
included
wide
variety
disorders,
changes
cycle
length
(
n
=
54),
amount
44),
menses
30),
experience
(pre)menstrual
pain
21),
breakthrough
18).
All
found
higher
percentage
at
least
one
disorder
first
different
types
doses.
Discussion:
In
conclusion,
evidence
suggests
that
may
cause
women
reproductive
age.
However,
there
need
more
longitudinal
because
important
limitations
study
designs
many
studies.
Although
short-lived
predominantly
mild,
it
healthcare
professionals
be
informed
about
these
potential
adverse
reactions
assess
events
clinical
trials
vaccines.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: Dec. 8, 2022
Background
Patients
with
type
2
diabetes
mellitus
(T2DM)
are
at
increased
risk
for
COVID-19
related
morbidity
and
mortality.
Antibody
response
to
vaccine
in
T2DM
patients
is
not
very
clear.
The
present
work
aims
evaluate
the
antibody
inactivated
SARS-CoV-2
this
population.
Methods
Two
groups
of
subjects
no
history
infection
were
included:
63
56
non-T2DM
controls.
Each
participant
received
two
doses
vaccine.
IgG
antibodies
against
nucleocapsid
(N)
spike
(S)
proteins
(anti-N/S
IgG)
receptor
binding
domain
(RBD)
(anti-RBD
quantitatively
evaluated
by
electrochemiluminescence
immunoassays,
respectively.
Results
It
was
observed
that
positive
rates
titers
anti-N/S
anti-RBD
significantly
lower
than
those
controls,
respectively
(anti-N/S:
85.7
vs.
98.2%,
P
=
0.034;
25.48
33.58
AU/ml
0.011;
anti-RBD:
96.4%,
0.044;
15.45
22.25
AU/ml,
0.019).
Compared
subjects,
uncontrolled
glycemia
showed
IgG:
75%
13.30
AU/ml;
11.91
respectively,
all
<
0.05),
while
controlled
had
similar
94.3%
33.65
19.82
>
0.05).
Conclusion
In
analysis
performed,
data
indicate
a
level
compared
non-diabetic
controls
individuals
when
immunized
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Sept. 27, 2022
Although
periconception
vaccination
is
important
to
maternal
and
neonatal
health,
little
known
about
the
COVID-19
vaccine
hesitancy
among
infertile
couples
seeking
fertility
treatment.
Thus,
we
conducted
this
survey
patients
in
a
reproductive
medicine
center,
between
September
2021
December
2021,
estimate
prevalence
of
its
influencing
factors.
Information
was
collected
through
face-to-face
interviews
volunteers.
Among
987
included
interviewees,
17.33%
reported
primary
vaccination,
25.63%
booster
32.32%
delayed
vaccination.
Hesitancy
associated
with
unexplained
infertility
(OR:
1.77,
95%
CI:
1.05-2.98),
ongoing
IVF
treatment
2.17,
1.22-3.89),
concerns
for
safety
4.13,
2.66-6.42),
effectiveness
1.62,
1.15-2.28),
influence
on
pregnancy
2.80,
1.68-4.67).
These
factors
were
also
Delay
inversely
college
or
above
degree
0.49,
0.27-0.87),
previous
history
influenza
0.67,
0.46-0.98),
positively
7.78,
5.01-12.07).
It
necessary
carry
out
targeted
education
program
by
health
professionals
publicize
benefits
reduce
resistance
couples.
Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine,
Journal Year:
2023,
Volume and Issue:
50(2), P. 69 - 77
Published: May 16, 2023
Coronavirus
disease
2019
(COVID-19)
vaccines
have
been
widely
administered
throughout
the
global
community
to
minimize
morbidity
and
mortality
caused
by
COVID-19
pandemic.
Although
generally
well-tolerated,
these
generated
some
unwanted
consequences,
including
thrombosis
menstrual
irregularities.
The
effect
of
vaccination
on
female
reproductive
function
has
also
questioned.
aim
this
review
is
give
readers
a
clear
understanding
effects
thrombosis,
function,
irregularities
systemically
analyzing
available
literature.
evidence
suggests
that
minimal
impact
ovarian
reserve.
Furthermore,
in
vitro
fertilization
outcomes
after
remain
unimpaired
compared
those
who
did
not
receive
vaccines.
Current
supports
certain
degree
cycle,
with
most
frequent
alteration
being
irregularity,
followed
menorrhagia.
These
changes
are
well-tolerated
transient,
lasting
less
than
2
months.
This
review,
providing
information
up-to-date
references
issue,
may
enhance
readers'
cycle.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: July 22, 2022
High
vaccination
coverage
is
essential
to
prevent
and
control
the
spread
of
COVID-19
epidemic.
Currently,
real-world
acceptance
vaccines
among
adolescents
aged
12–17
years
in
China
has
not
been
reported.
We
aimed
assess
rate
eastern
identify
factors
associated
with
intention
get
vaccinated
against
COVID-19.
conduct
a
cross-sectional
questionnaire
survey
from
three
provinces
part
16
August
28
October
2021.
The
questionnaires
were
distributed
2,100
students,
2,048
students
completed
questionnaires.
results
showed
that
98.4%
(2,016/2,048)
had
received
at
least
one
dose
vaccine
1.6%
(32/2,048)
declined
vaccination.
participants
rural
districts,
or
whose
parents
vaccinated,
more
likely
accept
vaccine.
main
reason
for
declining
was
worry
about
safety
(25%).
adverse
event
after
pain
injection
site.
In
conclusion,
reached
this
study,
which
met
criteria
herd
immunity
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
high
beneficial
prevention
pandemic.
BMC Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: June 5, 2024
Abstract
Background
China
experienced
an
overwhelming
COVID-19
pandemic
from
middle
December
2022
to
January
2023
after
lifting
the
zero-COVID-19
policy
on
7,
2022.
However,
infection
rate
was
less
studied.
We
aimed
investigate
SARS-CoV-2
in
children
shortly
discontinuation
of
policy.
Methods
From
February
20
April
10,
2023,
we
included
393
aged
8
months
than
3
years
who
did
not
receive
vaccination
and
114
6
received
inactivated
vaccines
based
convenience
sampling
this
cross-sectional
study.
IgG
IgM
antibodies
against
nucleocapsid
(N)
subunit
1
spike
(S1)
(anti-N/S1)
were
measured
with
commercial
kits
(Shenzhen
YHLO
Biotech,
China).
Results
Of
unvaccinated
(1.5
±
0.6
years;
52.2%
boys),
369
(93.9%)
anti-N/S1
positive.
vaccinated
(5.3
0.9
48.2%
112
(98.2%)
None
or
The
median
antibody
titers
(344.91
AU/mL)
significantly
higher
that
(42.80
(
P
<
0.0001).
positive
rates
had
no
significant
difference
between
boys
girls
respectively.
Conclusion
Vast
majority
infected
ending
China.
Whether
these
should
vaccine
merits
further
investigation.
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ),
Journal Year:
2024,
Volume and Issue:
7(1), P. 46 - 51
Published: July 8, 2024
Background:
The
implementation
of
vaccines
is
a
major
step
in
saving
humanity
from
the
consequences
COVID-19,
and
there
has
become
hope
for
everyone
world.
Menstruation
key
indicator
overall
women's
health.
COVID-19
vaccination
been
associated
with
changes
menstrual
cycle.
Objective:
To
evaluate
effects
on
Methods:
This
face-to-face
interview-based
cross-sectional
study
that
recruited
403
vaccinated
women
vaccine
who
had
normal
MC
before
receiving
at
least
six
months
Mosul,
Iraq,
February
1
to
July
31,
2022.
We
asked
about
their
cycle
parameters
after
vaccination.
results
were
analyzed
statistically.
Results:
most
frequent
age
group
among
participants
was
20–34
years
(52.9%).
About
half
(58.3%)
received
Pfizer
vaccine.
12.2%
13.65%
reported
significant
following
first
second
doses,
respectively.
These
included
irregularities
modifications
amount
duration
menses,
significantly
responsible
these
changes.
Conclusions:
In
small
number
vaccination,
post-Covid-19
occurred,
not
critical.
result
can
reassure
community
vaccine's
impact